Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic Arthritis in Germany

Overview of attention for article published in Applied Health Economics and Health Policy, November 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 73 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 07 Nov 2019

#HealthEconJA Cost Effectiveness of Secukinumab Versus Other Biologics and Apremilast in the Treatment of Active Psoriatic…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.